Korean J Gastroenterol.  2022 Oct;80(4):203-205. 10.4166/kjg.2022.115.

Association of Long-term Use of Proton Pump Inhibitors with Mortality

• Jung DH

• KMID: 2534471
• DOI: http://doi.org/10.4166/kjg.2022.115

Reference

1. Lo CH, Ni P, Yan Y, et al. 2022; Association of proton pump inhibitor use with all-cause and cause-specific mortality. Gastroenterology. 163:852–861.e2. DOI: 10.1053/j.gastro.2022.06.067. PMID: 35788344.

2. Colditz GA, Manson JE, Hankinson SE. 1997; The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 6:49–62. DOI: 10.1089/jwh.1997.6.49. PMID: 9065374.

3. Rimm EB, Giovannucci EL, Willett WC, et al. 1991; Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 338:464–468. DOI: 10.1016/0140-6736(91)90542-W.

4. Freedberg DE, Kim LS, Yang YX. 2017; The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 152:706–715. DOI: 10.1053/j.gastro.2017.01.031. PMID: 28257716.

5. Lanas-Gimeno A, Hijos G, Lanas Á. 2019; Proton pump inhibitors, adverse events and increased risk of mortality. Expert Opin Drug Saf. 18:1043–1053. DOI: 10.1080/14740338.2019.1664470. PMID: 31498687.

6. Shah NH, LePendu P, Bauer-Mehren A, et al. 2015; Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLoS One. 10:e0124653. DOI: 10.1371/journal.pone.0124653. PMID: 26061035. PMCID: PMC4462578.

7. Wang X, Liu Q, Halfdanarson ÓÖ, et al. 2021; Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study. Br J Cancer. 125:893–900. DOI: 10.1038/s41416-021-01480-0. PMID: 34253872. PMCID: PMC8438017.

8. Zirk-Sadowski J, Masoli JA, Delgado J, et al. 2018; Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults. J Am Geriatr Soc. 66:1332–1338. DOI: 10.1111/jgs.15385. PMID: 29676433. PMCID: PMC6099478.

9. Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O. 2019; Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis. Hepatology. 70:640–649. DOI: 10.1002/hep.30304. PMID: 30289992.

10. Douwes RM, Gomes-Neto AW, Eisenga MF, et al. 2020; The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: a cohort study. PLoS Med. 17:e1003140. DOI: 10.1371/journal.pmed.1003140. PMID: 32542023. PMCID: PMC7295199.

11. Tamim H, Monfared AA, LeLorier J. 2007; Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf. 16:250–258. DOI: 10.1002/pds.1360. PMID: 17245804.

12. Moayyedi P, Eikelboom JW, Bosch J, et al. 2019; Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology. 157:682–691.e2.

13. Baik SH, Fung KW, McDonald CJ. 2022; The mortality risk of proton pump inhibitors in 1.9 million US seniors: an extended cox survival analysis. Clin Gastroenterol Hepatol. 20:e671–e681. DOI: 10.1016/j.cgh.2021.01.014. PMID: 33453399.

14. He Q, Xia B, Meng W, et al. 2021; No associations between regular use of proton pump inhibitors and risk of all-cause and cause-specific mortality: a population-based cohort of 0.44 million participants. Am J Gastroenterol. 116:2286–2291. DOI: 10.14309/ajg.0000000000001377. PMID: 34313608. PMCID: PMC8560155.

15. Lazarus B, Chen Y, Wilson FP, et al. 2016; Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 176:238–246. DOI: 10.1001/jamainternmed.2015.7193. PMID: 26752337. PMCID: PMC4772730.

16. Klatte DCF, Gasparini A, Xu H, et al. 2017; Association between proton pump inhibitor use and risk of progression of chronic kidney disease. Gastroenterology. 153:702–710. DOI: 10.1053/j.gastro.2017.05.046. PMID: 28583827.

17. Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. 2017; Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney Int. 91:1482–1494. DOI: 10.1016/j.kint.2016.12.021. PMID: 28237709.